Cannabinoid Pathway Genetics

Cannabinoid pathway genetics refer to the hereditary factors controlling how cannabis plants synthesize and accumulate cannabinoids like THC, CBD, and CBG. These traits are regulated by enzyme-coding genes—particularly synthase and oxidase variants—that determine which cannabinoid precursors are produced and in what ratios. Breeders studying cannabinoid pathway genetics map these biosynthetic routes to predict offspring cannabinoid profiles more reliably than visual or growth traits alone. Different cultivar lineages carry distinct pathway alleles: some strains favor THCA synthase activity, others CBD synthase dominance, and emerging work explores CBGA and CBGVA pathways. Understanding cannabinoid pathway inheritance remains challenging due to polygenic control and environmental modulation, but advances in marker-assisted selection help breeders stabilize desirable chemotypes across gene

Breeders leverage cannabinoid pathway genetics to select parents that reliably produce target cannabinoid profiles—whether high-THC, high-CBD, or balanced ratios—without relying solely on phenotype observation. Molecular markers linked to synthase and oxidase genes accelerate identification of homozygous or heterozygous pathway alleles in breeding stock.